Deutsche Bank Downgrades AstraZeneca (AZN) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Deutsche Bank Downgrades AstraZeneca (AZN) to Hold
February 8, 2024 5:36 AM EST
Deutsche Bank analyst Emmanuel Papadakis downgraded AstraZeneca (AZN:LN) (NASDAQ: AZN) from Hold to Sell with a price target of GBP95.00 (from GBP110.00).
...
More
February 8, 2024 2:55 AM EST
AstraZeneca (NASDAQ: AZN) reported Q4 EPS of $1.45, $0.71 better than the analyst estimate of $0.74. Revenue for the quarter came in at $12.02 billion versus the consensus estimate of $12 billion.
GUIDANCE:
The Company issues its Total Revenue and Core EPS guidance for... More
February 7, 2024 6:53 AM EST
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it has expanded an existing program in Spain to increase access to local testing for homologous recombination deficiency (HRD) throughout the country. The expansion of the program, supported by AstraZeneca (NASDAQ: AZN) Spain and its network throughout the country, will further SOPHiA GENETICS' commitment to global health... More
